The Multiple Roles of the IAP Super-family in cancer

Swati Kumar1, Ciaran Fairmichael1, Daniel B Longley1

  • 1Centre for Cancer Research and Cell Biology, Queen's University of Belfast, Belfast, United Kingdom.

Insights

Inhibitor of Apoptosis proteins (IAPs) regulate cell death and signaling pathways. This review explores their roles in cancer hallmarks and emerging targeted therapies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Inhibitor of Apoptosis proteins (IAPs) are recognized for their anti-apoptotic functions and caspase inhibition.
  • Emerging evidence highlights IAPs' broader roles in cellular processes beyond apoptosis.
  • IAPs modulate ubiquitin-dependent signaling and nuclear factor κB (NF-κB) activation via E3 ligase activity.

Purpose of the Study:

  • To review the multifaceted roles of IAPs in cancer.
  • To discuss the involvement of IAPs in the hallmarks of cancer.
  • To summarize the current landscape of therapies targeting IAPs.

Main Methods:

  • Literature review of IAP functions in cancer.
  • Analysis of IAP involvement in cancer hallmarks.
  • Overview of current therapeutic strategies targeting IAPs.

Main Results:

  • IAPs are implicated in multiple cancer hallmarks, including proliferation, survival, and immune evasion.
  • Dysregulation of IAP pathways contributes to cancer development and progression.
  • Targeting IAPs presents a promising therapeutic avenue in oncology.

Conclusions:

  • IAPs are critical regulators with significant implications in cancer.
  • Therapeutic strategies targeting IAPs are under active investigation.
  • Further research into IAP biology may uncover novel cancer treatments.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K